© Reuters. “We Think There is a Good Chance of Broad-label Approval” – Needham & Company Bullish on Zealand Pharma (ZEAL) Following Phase 3 Data Needham & Company analyst Joseph Stringer reiterated a Buy rating […]
© Reuters. By Sam Boughedda Investing.com — NVIDIA’s (NASDAQ:) price target was cut at both Oppenheimer and Wedbush on Thursday, ahead of the company’s earnings release next week, May 25th. Oppenheimer analyst Rick Schafer trimmed his […]
© Reuters. FILE PHOTO: The Shaw Communications logo is seen at their office in Calgary, Alberta, Canada, April 17, 2019. REUTERS/Chris Wattie By Divya Rajagopal and David Ljunggren TORONTO (Reuters) – The Canadian federal government […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.